Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DaVita HealthCare Partner
(NY:
DVA
)
113.61
-0.21 (-0.18%)
Official Closing Price
Updated: 7:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DaVita HealthCare Partner
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
In today's session, there are S&P500 stocks with remarkable trading volume.
↗
February 14, 2025
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via
Chartmill
Discover which S&P500 stocks are making waves on Friday.
↗
February 14, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
These S&P500 stocks are gapping in today's session
↗
February 14, 2025
Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
Which S&P500 stocks are moving before the opening bell on Friday?
↗
February 14, 2025
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Via
Chartmill
Earnings Scheduled For February 13, 2025
↗
February 13, 2025
Via
Benzinga
What Analysts Are Saying About DaVita Stock
↗
October 07, 2024
Via
Benzinga
Key Takeaways From DaVita Analyst Ratings
↗
August 08, 2024
Via
Benzinga
Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
February 14, 2025
Via
Benzinga
DaVita Plunges Over 10% In Friday Pre-Market After Warren Buffett Cuts Stake In One Of Berkshire Hathaway's Longest-Held Investments
↗
February 14, 2025
The shares of DaVita Inc.(NYSE: DVA) plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for...
Via
Benzinga
Warren Buffett's Berkshire Hathaway Sells Nearly $36 Million Worth Of Dialysis Giant DaVita's Shares Amid Q4 Earnings Beat
↗
February 14, 2025
Warren Buffett's Berkshire Hathaway has cut its stake in the dialysis provide DaVita Inc according to a U.S. SEC filing.
Via
Benzinga
Topics
Regulatory Compliance
DaVita (DVA) Q4 2024 Earnings Call Transcript
↗
February 13, 2025
DVA earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
DaVita (NYSE:DVA) Posts Better-Than-Expected Sales In Q4 But Stock Drops
February 13, 2025
Dialysis provider DaVita Inc. (NYSE:DVA) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $3.29 billion. Its non-GAAP profit of $2.24 per share was 4.3% above...
Via
StockStory
DaVita (DVA) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 12, 2025
Dialysis provider DaVita Inc. (NYSE:DVA) will be announcing earnings results tomorrow after market close. Here’s what to look for.
Via
StockStory
2 Warren Buffett Stocks to Buy Without Hesitation If You Have $1,000 to Invest Right Now
↗
February 02, 2025
Via
The Motley Fool
3 No-Brainer Warren Buffett Stocks to Buy Right Now
↗
February 02, 2025
Via
The Motley Fool
The Best Warren Buffett Stocks to Buy With $250 Right Now
↗
December 22, 2024
Via
The Motley Fool
DaVita Stock Sees Improved Relative Strength Rating
↗
December 20, 2024
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.
Via
Investor's Business Daily
The Best Warren Buffett Stocks to Buy With $1,000 Right Now
↗
November 25, 2024
Here are three of Warren Buffett's highest-conviction stocks.
Via
The Motley Fool
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
↗
November 17, 2024
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.
Via
Benzinga
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
↗
November 14, 2024
GOP control of Congress under Trump could lead to a surge in M&A activity, especially in banks and biotech. Factors like equity market returns and rate cuts could fuel deals, with small-cap targets and...
Via
Benzinga
Topics
Government
Why DaVita Stock Withered on Wednesday
↗
October 30, 2024
The company's profitability is going in the wrong direction for many investors.
Via
The Motley Fool
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
↗
October 30, 2024
This week marks a firehose of earnings from several top Buffett holdings.
Via
Investor's Business Daily
DaVita (DVA) Q3 2024 Earnings Call Transcript
↗
October 29, 2024
DVA earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 29, 2024
Via
Benzinga
3 Buy Rated Stocks Cruising At 52 Week Highs
↗
October 02, 2024
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are rolling in. Let’s take a closer look at what’s been driving the bullish...
Via
Talk Markets
AdaptHealth Stock Earns RS Rating Upgrade
↗
September 17, 2024
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81.
Via
Investor's Business Daily
3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
↗
September 14, 2024
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,...
Via
Talk Markets
Bull Of The Day: Davita - Friday, September 6
↗
September 06, 2024
Known to be the most volatile month for stocks, September is when many investors rebalance their portfolios to include less risky assets such as equities that provide exposure to essential healthcare...
Via
Talk Markets
Top Medical Stocks To Hedge Against The September Effect
↗
September 04, 2024
While the Fed will likely cut interest rates in the coming weeks, September has historically been the most challenging month for stocks. Here are three top medical stocks to hedge against the September...
Via
Talk Markets
Topics
Economy
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
↗
August 13, 2024
The AI chipmaker has enjoyed a tremendous run-up, but its sky-high valuation means there are better stocks to buy than Nvidia.
Via
InvestorPlace
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today